BamOmaB

Bamomab

BamOmaB was founded in 2006 in order to provide newly developed, high-quality reagents for immunological research to the scientific community. These reagents primarily include novel monoclonal antibodies and ELISA-kits developed in the Department of Immunology of the University of Tuebingen.

BAMOMAB GmbH
Ruffiniallee 15a
82166 Gräfelfing
Germany

Phone : +49-7071-255087
Fax: +49-(0)89-3303-7335